1-6 of 6
Erinn Downs-Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study

Open Access
H. Evin Gulbahce, MD, MSCI, Erinn Downs-Kelly, DO, Kimberly A. Herget, MStat, Gregory J. Stoddard, MBA, MPH
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2021) 146 (4): 478–484.
https://doi.org/10.5858/arpa.2020-0837-OA
Published: 03 August 2021
View articletitled, The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study
Open the PDF for The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study in another window
Journal Articles

RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory

Open Access
Ling Hui, MD, PhD, Katherine B. Geiersbach, MD, Erinn Downs-Kelly, DO, H. Evin Gulbahce, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2016) 141 (2): 274–278.
https://doi.org/10.5858/arpa.2016-0201-OA
Published: 13 December 2016
View articletitled, RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory
Open the PDF for RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory in another window
Journal Articles

Automated Bright-Field Dual-Color In Situ Hybridization for MDM2 : Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults

Open Access
Gloria Zhang, MD, Christopher P. Lanigan, MS, John R. Goldblum, MD, Raymond R. Tubbs, DO, Erinn Downs-Kelly, DO
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2016) 140 (10): 1111–1115.
https://doi.org/10.5858/arpa.2015-0249-OA
Published: 01 October 2016
View articletitled, Automated Bright-Field Dual-Color In Situ Hybridization for MDM2 : Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults
Open the PDF for Automated Bright-Field Dual-Color In Situ Hybridization for MDM2 : Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults in another window
Journal Articles

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer

Open Access
H. Evin Gulbahce, MD;, Rachel Factor, MD;, Katherine Geiersbach, MD;, Erinn Downs-Kelly, DO
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2016) 140 (8): 741.
https://doi.org/10.5858/arpa.2016-0015-LE
Published: 01 August 2016
View articletitled, HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer
Open the PDF for HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer in another window
Journal Articles

Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ

Open Access
Erinn Downs-Kelly, DO, Diana Bell, MD, George H. Perkins, MD, Nour Sneige, MD, Lavinia P. Middleton, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2011) 135 (6): 737–743.
https://doi.org/10.5858/2010-0204-OA.1
Published: 01 June 2011
View articletitled, Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ
Open the PDF for Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ in another window
Journal Articles

Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms: An Institutional Experience

Open Access
Munir R. Tanas, MD, Brian P. Rubin, MD, PhD, Raymond R. Tubbs, DO, Steven D. Billings, MD, Erinn Downs-Kelly, DO ...
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2010) 134 (12): 1797–1803.
https://doi.org/10.5858/2009-0571-OAR.1
Published: 01 December 2010
View articletitled, Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms: An Institutional Experience
Open the PDF for Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms: An Institutional Experience in another window